Training & Events

Health Canada And FDA Required Pharmacovigilance And Product Safety Reporting For The Medical And Recreational Cannabis Industry

BAM Members please contact Sheri Huetter at sheri@biomb.ca to register and for subsidized pricing.

Important: The Webinar is in Eastern Standard Time.

Course Outline:

  1. Pharmacology of Cannabis products
  2. Pathologies related to the use of Cannabis products
  3. Safety issues reported to health Canada and FDA on the use of Cannabis products
  4. ICH-Good Vigilance Practice (GVP) and reporting of safety cases to regulatory Authorities
  5. Canadian guideline for prescribing medical cannabinoids in primary care
  6. Establishment of your company Pharmacovigilance system
  7. Your company mandatory annual training on processing of safety reports

SPEAKER: Peivand Pirouzi, Ph.D., MBA. CCPE

Peivand holds a Ph.D. in Physiology and Biophysics from School of Medicine, University of Sherbrook, and MBA from American Business Administration Institute, and he is accredited by the Canadian Council of Pharmaceutical Education with certifications in Evidence Based Medicine, Psychiatry, and Management.

Peivand’s industrial experience includes Wyeth/Pfizer, ApoPharma/Apotex, as well as collaborations with EliteMed and Medipure Pharmaceuticals. His government and corporate training experience covers companywide pharmaceutical and sales training on a multitude of subjects.

He has extensive pharmaceutical teaching experience to personnel ranging from Health Canada Inspectorate (in pharmacovigilance) to pharma industry organizations such as Nestle, Teva, Biopharma Services, 3M, Medipure Pharmaceuticals, and Patheon.

He has authored more than 65 scientific realizations, including 12 publications in the National Library of Canada, articles in peer-reviewed journals, oral and poster presentations, and more than 1000 technical and scientific reports.

https://psg.ca/events/health-canada-and-fda-required-pharmacovigilance-and-product-safety-reporting-for-the-medical-and-recreational-cannabis-industry/

Back